Today—October 26, 2015—LifeBridge, LLC entered the National Phase of the Patent Coperation Treaty (PCT) process and was granted temporary patent protection in 148 countries for 30 months. The PCT’s International Searching Authority searched the world with three criterea in mind.
1. Novel: In the context of a patent application, an invention is considered novel when it is different from all previous inventions (called "prior art") in one or more of its constituent elements.
2. Inventive: The “Inventive step” states that the invention should be sufficiently inventive—i.e., non-obvious in order to be patented. The invention should be significantly different than prior art.
3. Industrial Applicability: The invention must be susceptible of industrial application. The invention must be likely to have an application.
The PCT examiners found the LifeBridge invention to be novel, inventive and to have industrial application in all 18 of its primary claims. This non-controversial approval usually indicates favorable decisions from member countries when applying for long-term protection. In the coming months, the company will be confirming its plan of action for filing of long-term protection in select countries.